bromodeoxyuridine has been researched along with fasudil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Li, QY; Lu, CZ; Sun, CH; Wang, X; Xiao, BG; Yu, JZ | 1 |
| Guo, Y; Zhai, Z | 1 |
2 other study(ies) available for bromodeoxyuridine and fasudil
| Article | Year |
|---|---|
Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult Stem Cells; Animals; Antibodies; Astrocytes; Brain Injuries; Bromodeoxyuridine; CD11b Antigen; Cell Movement; Cells, Cultured; Cerebral Ventricles; Choline O-Acetyltransferase; Cytokines; Disease Models, Animal; Doublecortin Domain Proteins; Embryo, Mammalian; Granulocyte Colony-Stimulating Factor; Hydro-Lyases; Hypoxia; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurons; Neuropeptides; Oxygen; Protein Kinase Inhibitors; rho-Associated Kinases; Statistics, Nonparametric | 2010 |
Combination of constraint-induced movement therapy with fasudil amplifies neurogenesis after focal cerebral ischemia/reperfusion in rats.
Topics: Animals; Brain Ischemia; Bromodeoxyuridine; Cerebral Infarction; Neurogenesis; Nogo Proteins; Rats; Reperfusion Injury; Stroke | 2022 |